NCT02935400View on ClinicalTrials.gov

Acute Porphyria Biomarkers for Disease Activity

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 28, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
Interventions
DRUG

Hemin

Hemin will be administered under a separate protocol or for clinical treatment, and samples will be collected under this protocol before and after treatment.

Trial Locations (1)

77555

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT02935400 - Acute Porphyria Biomarkers for Disease Activity | Biotech Hunter | Biotech Hunter